Parasite

Quinfamide is an antiamebic agent. Quinfamide can be used to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.

Symetine is an antiparasitic and antispirochete agent.

Sinefungin is a potent inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2'-)-methyltransferase, and viral multiplication.

Gallinamide A TFA is a potent inhibitor of cathepsin L (CatL), with an IC50 of 17.6 pM. This peptide demonstrates significant antiviral activity by inhibiting SARS-CoV-2 infection, with an EC50 of 28 nM. Additionally, Gallinamide A TFA effectively inhibits Plasmodium falciparum, exhibiting an IC50 of 50 nM, making it a valuable reagent for research into parasitic infections and viral therapies.

D-Arabinose functions as an anti-parasitic agent with a notable capability to inhibit the growth of Caenorhabditis elegans, exhibiting an IC50 of 7.5 mM. This compound effectively penetrates the blood-brain barrier and selectively interferes with the metabolism of D-ribose and D-fructose. Additionally, D-Arabinose demonstrates antibacterial properties by inhibiting biofilm synthesis and activates the ACSS2-PPARγ/TFEB-CRTC1 axis via the lysosomal AXIN-LKB1-AMPK pathway, contributing to its antidepressant-like effects. D-Arabinose serves as the ring-opened form of the aldopentose D-arabinose.

CpCDPK1/TgCDPK1-IN-1 is a potent dual inhibitor of CpCDPK1 and TgCDPK1, demonstrating IC50 values of 10 nM and 5.0 nM, respectively. In addition, it shows inhibitory activity against Abl and Src kinases with IC50 values of 75 nM and 65 nM. This compound is suitable for research applications related to toxoplasmosis, providing valuable insights into the therapeutic targeting of these pathways.

Antileishmanial agent-36 is an indole-dihydropyrimidinone derivative that targets Leishmania species, demonstrating significant anti-leishmanial activity. This compound induces mitochondrial dysfunction through the generation of reactive oxygen species (ROS), leading to apoptosis in infected cells. It exhibits potent lethality against L. donovani with an IC50 value of 4.54 µM, while displaying low cytotoxicity towards J774.1 macrophages. Antileishmanial agent-36 is suitable for research applications focused on visceral leishmaniasis (VL) and parasite burden clearance.

Quinacrine acetate is a potent modulator of the cGAS-STING-TBK1 signaling pathway, exhibiting notable immune stimulatory activity. This compound has been investigated for its therapeutic potential in enhancing anti-tumor immunity and improving the efficacy of cancer immunotherapies by addressing the immunogenicity challenges faced by various tumors. Quinacrine acetate also represents a promising approach to mitigate the limitations associated with immune checkpoint inhibitors in cancer treatment.

PT4 is an antileishmanial agent specifically effective against cutaneous leishmaniasis. It exhibits significant activity against both Leishmania species, with IC50 values of 125.18 µM for L. amazonensis and 233.18 µM for L. braziliensis. PT4 induces a reduction in mitochondrial membrane potential and elevates reactive oxygen species production, resulting in parasite lethality. Additionally, PT4 demonstrates potent in vivo anti-inflammatory properties, making it a valuable tool for research in leishmaniasis and related inflammatory conditions.

Antileishmanial agent-35 is a potent antileishmanial compound that targets Leishmania amazonensis, exhibiting an IC50 of 0.29 μM against promastigotes. This compound disrupts mitochondrial function by lowering the mitochondrial membrane potential and ATP levels, while also enhancing reactive oxygen species (ROS) production due to interference with the electron transport chain. Antileishmanial agent-35 is suitable for research focused on cutaneous leishmaniasis and its underlying mechanisms of action.

N-(2-Hydroxypropyl)methacrylamide functions as a key building block for the synthesis of copolymers aimed at targeted drug delivery in the treatment of visceral leishmaniasis (VL). This compound enhances the efficacy of antileishmanial agents by facilitating their selective transport to the affected tissues. Its application in polymer chemistry supports advanced therapeutic approaches in combating leishmaniasis.

Albendazole sulfoxide, the principal active metabolite of Albendazole, acts as a potent inhibitor of parasite growth. It demonstrates significant anti-parasitic activity against Echinococcus multilocularis metacestodes, making it valuable in the study of parasitic infections and potential therapeutic interventions. This compound is utilized in research focused on parasitology and drug efficacy against helminthic diseases.

Oxfendazole is a sulfoxide derivative of fenbendazole that targets parasitic organisms through inhibition of energy metabolism. Its primary biological activity is the effective combat against a broad spectrum of parasites. This compound is utilized in research focused on parasitology and can also be studied for its potential effects in tumor promotion investigations.

β-Hederin is a saponin derived from Hedera helix L. (Araliaceae) that demonstrates significant antileishmanial activity. It exhibits IC50 values of 1.5 μM against L. mexicana promastigotes, 68 nM against L. mexicana amastigotes, and 4.57 μM in THP-1 cells. This compound may be utilized in research applications targeting leishmaniasis, providing insights into potential therapeutic strategies against parasitic infections.

Morantel tartrate is an effective anthelmintic agent targeting gastrointestinal parasites. It is primarily utilized in veterinary medicine to control subclinical gastrointestinal parasitism in cattle on pasture. Following administration, morantel tartrate can be detected in ruminal, abomasal, ileal fluids, and feces for up to 98 days, indicating its prolonged activity. This compound is instrumental in research related to parasitic infections and antiparasitic drug development.

SC83288 is an inhibitor of PfDNMT2 in Plasmodium falciparum, with an IC50 of 7 μM. This compound disrupts the epigenetic regulation within malaria parasites, impeding DNA replication and nuclear division, and consequently arrests the development of the asexual blood stage. SC83288 also induces pyknotic morphology in the parasites without impacting cytokinesis post-nuclear division or parasite egress, making it valuable for malaria-related research applications.